Our History in a Nutshell

Expanding the World of Mid-Size Protein Biologics

The foundations of X’PROCHEM go back to 2012 when 3 scientists, Reda MHIDIA, Julien DHEUR and Oleg MELNYK, decided to put together their expertise in chemical synthesis of mid-size proteins.

Some Milestones

  • 2012: Incorporation of X’PRCHEM and establishment at Pasteur Institute in Lille (France)
  • 2012: Award i-Lab Nord-Pas-De-Calais 1st Prize  
  • 2015: Expansion of our proprietary Fragments Ligation Technology
  • 2018: Successful of Capital Increase with Business Angels, Public and Private Funds 
  • 2019: Move to EURASANTÉ’s BioIncubator
  • 2019: 1st ever chemical synthesis of Interferon alpha 2a
  • 2020: Portfolio of co-development innovative mid-size protein-based drugs